Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Gonçalves de Oliveira Lucas, Patrick Wong, Jon Klein et al. · Nature · 2020
Cited by 2,060 works. doi:10.1038/s41586-020-2588-y Open-access PDF
Authors
- Carolina Gonçalves de Oliveira Lucas
- Patrick Wong
- Jon Klein
- Tiago B. R. Castro
- Júlio Dos Santos Silva
- Maria E. Sundaram
- Mallory K. Ellingson
- Tianyang Mao
- Ji Eun Oh
- Benjamin Israelow
- Takehiro Takahashi
- Maria Tokuyama
- Peiwen Lu
- Arvind Venkataraman
- Annsea Park
- Subhasis Mohanty
- Haowei Wang
- Anne L. Wyllie
- Chantal B. F. Vogels
- Rebecca Earnest
References
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- Cytokine release syndrome in severe COVID-19